
Cagent Vascularrevenue
Wayne, PennsylvaniaFounded 2014CEO Brian Walsh
Cagent Vascular Inc. is a developer of next generation angioplasty balloons using Serration Technology for the treatment of cardiovascular disease.
Cagent Vascular revenue
Cagent Vascular has not published its revenue. Growjo puts it at about $25.4M a year (September 2025).
| As of | Revenue | Source |
|---|---|---|
| Sep 2025 | $25.4MEST | Growjo estimate |
Cagent Vascular CEO & employees
Brian Walsh is CEO of Cagent Vascular. Cagent Vascular has 72 employees (September 2025, LinkedIn).
- Brian WalshCEO
Cagent Vascular FAQ
What is Cagent Vascular's revenue?
Growjo estimates Cagent Vascular's revenue at about $25.4M a year (September 2025). The company hasn't published its own figure.
How many employees does Cagent Vascular have?
Cagent Vascular has 72 employees as of September 2025, according to LinkedIn.
Who is the CEO of Cagent Vascular?
Brian Walsh is the CEO of Cagent Vascular.
Categories
Companies in
How this page is sourced
1 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 10, 2026Data disclaimerReport a correctionClaim this profileRun Cagent Vascular? Join the podcast